Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD-Reference-Cited by-同舟云学术

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD

Published:2015-05-12 Issue:10 Volume:26 Page:2328-2339
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Isakova Tamara,Ix Joachim H.,Sprague Stuart M.,Raphael Kalani L.,Fried Linda,Gassman Jennifer J.,Raj Dominic,Cheung Alfred K.,Kusek John W.,Flessner Michael F.,Wolf Myles,Block Geoffrey A.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference102 articles.

1. Cognitive and physical function in chronic kidney disease

2. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

3. Medical Costs of CKD in the Medicare Population

4. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

5. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of circulating calcitriol in cardiovascular disease;The Journal of Steroid Biochemistry and Molecular Biology;2024-07

2. Effect of Lanthanum Carbonate on Serum Phosphate, Oxidative Stress, and Vascular Dysfunction in CKD;Kidney360;2024-05-23

3. Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with CKD;Kidney360;2024-04-04

4. FGF23 and klotho at the intersection of kidney and cardiovascular disease;Nature Reviews Cardiology;2023-07-13

5. The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?;Clinical Kidney Journal;2023-06-27